{"data":[{"accessionNo":"0001104659-26-062718","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"AgomAb Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"Common Shares, no nominal value per share","eventDate":"2026-03-31","reportingPerson":"Redmile Biopharma Investments III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2735926,"percentOfClass":5.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001104659-26-062718","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"AgomAb Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"Common Shares, no nominal value per share","eventDate":"2026-03-31","reportingPerson":"Jeremy C. Green","reportingCik":null,"personType":"HC,IN","sharesOwned":2735926,"percentOfClass":5.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001104659-26-062718","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"AgomAb Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"Common Shares, no nominal value per share","eventDate":"2026-03-31","reportingPerson":"Redmile Group, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":2735926,"percentOfClass":5.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001172661-26-002216","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"Agomab Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"American Depositary Shares, each representing one common share, no nominal value per share","eventDate":"2026-03-31","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2465348,"percentOfClass":5.01,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001172661-26-002216","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"Agomab Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"American Depositary Shares, each representing one common share, no nominal value per share","eventDate":"2026-03-31","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":2465348,"percentOfClass":5.01,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001193125-26-207455","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"AgomAb Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"Common Shares, no nominal value per share (\"Common Shares\")","eventDate":"2026-03-31","reportingPerson":"SANOFI","reportingCik":null,"personType":"CO","sharesOwned":2783096,"percentOfClass":5.71,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001213900-26-044365","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"Agomab Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"Common Shares, no nominal value per share","eventDate":"2026-03-31","reportingPerson":"Ran Nussbaum","reportingCik":null,"personType":"IN","sharesOwned":3305846,"percentOfClass":6.8,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001213900-26-044365","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"Agomab Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"Common Shares, no nominal value per share","eventDate":"2026-03-31","reportingPerson":"Tomer Kariv","reportingCik":null,"personType":"IN","sharesOwned":3305846,"percentOfClass":6.8,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001213900-26-044365","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"Agomab Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"Common Shares, no nominal value per share","eventDate":"2026-03-31","reportingPerson":"Pontifax Management 4 G.P. (2015) Ltd.","reportingCik":null,"personType":"CO","sharesOwned":3305846,"percentOfClass":6.8,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001213900-26-044365","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"Agomab Therapeutics NV","ticker":"AGMB","cusip":"00860C102","securityClass":"Common Shares, no nominal value per share","eventDate":"2026-03-31","reportingPerson":"Pontifax VI G.P. L.P.","reportingCik":null,"personType":"PN","sharesOwned":3305846,"percentOfClass":6.8,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0000315066-26-000646","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"AGOMAB THERAPEUTICS SA","ticker":"AGMB","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":4873680,"percentOfClass":10,"filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0000315066-26-000646","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002020932","issuerName":"AGOMAB THERAPEUTICS SA","ticker":"AGMB","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":4873680,"percentOfClass":10,"filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001193125-26-052946","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002020932","issuerName":"AgomAb Therapeutics NV","ticker":"AGMB","cusip":null,"securityClass":"Common Shares, no nominal value per share (\"Common Shares\")","eventDate":"2026-02-09","reportingPerson":"LSP 7 Cooperatieve U.A.","reportingCik":"0001876264","personType":"OO","sharesOwned":5141992,"percentOfClass":10.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"},{"accessionNo":"0001193125-26-052946","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0002020932","issuerName":"AgomAb Therapeutics NV","ticker":"AGMB","cusip":null,"securityClass":"Common Shares, no nominal value per share (\"Common Shares\")","eventDate":"2026-02-09","reportingPerson":"LSP 7 Management B.V.","reportingCik":null,"personType":"OO","sharesOwned":5141992,"percentOfClass":10.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/agmb"}],"updatedAt":"2026-10-23T20:18:32.447Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/agmb","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}